Social isolation refers to limited social contact and interaction with others, resulting in feelings of loneliness and disconnection. It disproportionately affects the elderly due to factors like loss of friends and family, retirement, reduced mobility, ageism, and limited access to technology. The elderly are at higher risk of social isolation as they may experience a shrinking social circle and face barriers to social participation. Social isolation has significant detrimental effects on their mental and physical well-being, leading to increased rates of depression, anxiety, cognitive decline, and reduced quality of life. Addressing social isolation among the elderly is crucial for promoting their overall health and happiness.
Social prescribing is a healthcare approach that recognises the importance of social factors in overall well-being. It involves connecting individuals with non-medical activities and community resources to improve their health and quality of life. Healthcare professionals, such as doctors or social workers, “prescribe” activities like art classes, gardening, exercise groups, or support groups, which can address underlying social determinants of health and promote holistic well-being. By addressing social isolation, mental health, and lifestyle factors, social prescribing aims to enhance individual health outcomes and reduce the burden on healthcare services.
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 2 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people involved in the Connect Local program under the Connecting Communities to Care 4 year program. The free program for over 65’s promotes wellbeing through social connection and is underway in the Glen Eira community in Melbourne.
- Deidre McGill, Executive General Manager, At Home Support, Bolton Clarke
- Ann Van Leerdam, Connect Local Community Connector, Bolton Clarke
- Dr Rajna Ogrin, Senior Research Fellow, Bolton Clarke Research Institute, Bolton Clarke
- Dr Daniel Fineberg, Deputy Director General Medicine, Alfred Hospital, Victoria
Also to watch
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia.
Produced with assistance from Australian Primary Health Care Nurses Association (APNA) and Bolton Clarke
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
